Iris Bica joined the CTL at Weill Cornell Medicine in the NYC office as a Business Development and Licensing Associate in November 2022. In this role, she assists the CTL@WCM team with identifying, assessing, and marketing their portfolio of life science technologies.
Before joining the team, Iris gained experience in business development and technology transfer at Tulane University’s Office of Intellectual Property Management and CancerTools.org, the reagent arm of Cancer Research UK. Iris holds a BS in Cell and Molecular Biology from Tulane University.
